165 related articles for article (PubMed ID: 30052477)
1. Characterization of FGD5 Expression in Primary Breast Cancers and Lymph Node Metastases.
Valla M; Mjønes PG; Engstrøm MJ; Ytterhus B; Bordin DL; van Loon B; Akslen LA; Vatten LJ; Opdahl S; Bofin AM
J Histochem Cytochem; 2018 Nov; 66(11):787-799. PubMed ID: 30052477
[TBL] [Abstract][Full Text] [Related]
2. FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis.
Valla M; Engstrøm MJ; Ytterhus B; Hansen ÅK; Akslen LA; Vatten LJ; Opdahl S; Bofin AM
Breast Cancer Res Treat; 2017 Apr; 162(2):243-253. PubMed ID: 28124285
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of androgen receptors in breast cancer subtypes.
Kraby MR; Valla M; Opdahl S; Haugen OA; Sawicka JE; Engstrøm MJ; Bofin AM
Breast Cancer Res Treat; 2018 Nov; 172(2):283-296. PubMed ID: 30109519
[TBL] [Abstract][Full Text] [Related]
4. High Expression of CCR7 Predicts Lymph Node Metastasis and Good Prognosis in Triple Negative Breast Cancer.
Li X; Sun S; Li N; Gao J; Yu J; Zhao J; Li M; Zhao Z
Cell Physiol Biochem; 2017; 43(2):531-539. PubMed ID: 28930757
[TBL] [Abstract][Full Text] [Related]
5. Expression of FGD3 gene as prognostic factor in young breast cancer patients.
Renda I; Bianchi S; Vezzosi V; Nori J; Vanzi E; Tavella K; Susini T
Sci Rep; 2019 Oct; 9(1):15204. PubMed ID: 31645624
[TBL] [Abstract][Full Text] [Related]
6. Low mutation and neoantigen burden and fewer effector tumor infiltrating lymphocytes correlate with breast cancer metastasization to lymph nodes.
Wang Z; Liu W; Chen C; Yang X; Luo Y; Zhang B
Sci Rep; 2019 Jan; 9(1):253. PubMed ID: 30670769
[TBL] [Abstract][Full Text] [Related]
7. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
8. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
Shigematsu H; Nishina M; Yasui D; Hirata T; Ozaki S
World J Surg Oncol; 2019 Feb; 17(1):41. PubMed ID: 30797231
[TBL] [Abstract][Full Text] [Related]
9. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
10. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.
Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351
[TBL] [Abstract][Full Text] [Related]
11. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of gap junction protein--connexin 32 in lymph node metastases of human ductal breast cancer.
Kanczuga-Koda L; Sulkowska M; Koda M; Rutkowski R; Sulkowski S
Folia Histochem Cytobiol; 2007; 45 Suppl 1():S175-80. PubMed ID: 18292829
[TBL] [Abstract][Full Text] [Related]
13. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
Falck AK; Fernö M; Bendahl PO; Rydén L
World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203
[TBL] [Abstract][Full Text] [Related]
14. Tumor labeling indices of primary breast cancers and their regional lymph node metastases.
Goodson WH; Ljung BM; Moore DH; Mayall B; Waldman FM; Chew K; Benz CC; Smith HS
Cancer; 1993 Jun; 71(12):3914-9. PubMed ID: 8508357
[TBL] [Abstract][Full Text] [Related]
15. Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
Tang C; Wang P; Li X; Zhao B; Yang H; Yu H; Li C
PLoS One; 2017; 12(8):e0182953. PubMed ID: 28806399
[TBL] [Abstract][Full Text] [Related]
16. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer.
Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
Arch Surg; 1993 Feb; 128(2):242-6. PubMed ID: 8094282
[TBL] [Abstract][Full Text] [Related]
17. [Significance of expression of stromal cell derived factor 1 and CXCR4 in invasive breast cancer].
Liu FF; Wei J; Lang RG; Fan Y; Cui LF; Gu F; Fu L
Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):529-35. PubMed ID: 19094464
[TBL] [Abstract][Full Text] [Related]
18. Expression of 6 common antigenic markers in invasive ductal breast carcinoma: potential clinical implications.
Lialiaris TS; Kouskoukis A; Georgiou G; Tripsianis G; Fiska A; Giatromanolaki A; Chrisafi S; Sivridis E; Vamvakopoulou DN; Soutopoulou DO; Kiritsaka A; Athanassiou E; Lialios GA; Sotiriou S; Sidiropoulos A; Vamvakopoulos NC
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):106-11. PubMed ID: 20724920
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
[TBL] [Abstract][Full Text] [Related]
20. Correlations between HER2 Expression and Other Prognostic Factors in Breast Cancer: Inverse Relations with the Ki-67 Index and P53 Status.
Payandeh M; Shahriari-Ahmadi A; Sadeghi M; Sadeghi E
Asian Pac J Cancer Prev; 2016; 17(3):1015-8. PubMed ID: 27039719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
